Publicaciones en las que colabora con JOSÉ MARÍA LADERO QUESADA (5)

2013

  1. Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: Efficacy and safety data according to liver function

    Clinical and Translational Oncology, Vol. 15, Núm. 2, pp. 146-153

2007

  1. Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients

    BMC Cancer, Vol. 7

2006

  1. Glutathione S-transferases μ1, θ1, π1 α1 and μ3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans

    Pharmacogenomics, Vol. 7, Núm. 5, pp. 711-718

2001

  1. Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk

    Carcinogenesis, Vol. 22, Núm. 8, pp. 1323-1326

2000

  1. N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: Risk variability according to tumour site?

    Scandinavian Journal of Gastroenterology, Vol. 35, Núm. 10, pp. 1087-1091